Thermo Fisher Scientific Analyst Price Targets

Wall Street analyst price targets and consensus rating for Thermo Fisher Scientific (TMO).

Price Target Range — 11 Quarters

Analyst Consensus — 27 Analysts

23Buy

4Hold

Consensus RatingBuy# Analysts27Avg. Consensus PT$635Upside to Avg. PT-1.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$650→$750
Sep 9, 2026	UBS	Doug Schenkel	Assumes	Neutral→Buy	$540→$730
Sep 3, 2026	CLSA	Michael Luo	Initiate	Outperform	$748
Jul 27, 2026	Piper Sandler	David Westenberg	PT Raise	Neutral	$510→$600
Jul 27, 2026	Morgan Stanley	Tejas Savant	PT Raise	Overweight	$620→$650
Jul 24, 2026	RBC Capital	Dan Leonard	PT Raise	Sector Perform	$490→$580
Jul 24, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$625→$650
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$575→$570
Jun 26, 2026	Bernstein	Eve Burstein	Reinstates	Market Perform	$520
Jun 11, 2026	Piper Sandler	David Westenberg	Initiate	Neutral	$510
Jun 3, 2026	HSBC	Sidharth Sahoo	Downgrade	Buy→Hold	$670→$540
Jun 2, 2026	Wolfe Research	Mike Polark	Assumes	Outperform	$535
May 8, 2026	Wells Fargo	Brandon Couillard	PT Cut	Overweight	$675→$615
Apr 24, 2026	Stifel	Daniel Arias	PT Cut	Buy	$700→$600
Apr 24, 2026	Baird	Catherine Schulte	PT Cut	Outperform	$653→$639
Apr 14, 2026	Barclays	Luke Sergott	PT Cut	Overweight	$650→$625
Apr 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$650→$575
Jan 30, 2026	TD Cowen	Dan Brennan	PT Cut	Buy	$696→$683
Jan 30, 2026	Citigroup	Patrick Donnelly	PT Raise	Buy	$660→$685
Jan 30, 2026	Barclays	Luke Sergott	PT Raise	Overweight	$625→$650

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750

Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $650 to $750.

Benzinga Newsdesk

PRO
CNBC Halftime Report Final Trades: Nutrien, Horizon Kinetics Inflation Beneficiaries ETF, Wells Fargo, Thermo Fisher Scientific

Benzinga Newsdesk

PRO
UBS Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $730

UBS analyst Doug Schenkel assumes Thermo Fisher Scientific (NYSE:TMO) with a Buy rating and raises Price Target to $730.

Benzinga Newsdesk

PRO
CLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748

CLSA analyst Michael Luo initiates coverage on Thermo Fisher Scientific (NYSE:TMO) with a Outperform rating and announces Price Target of $748.

Benzinga Newsdesk

PRO
CNBC Halftime Report Final Trades: Interactive Brokers Group, Target, Delta Air Lines, Thermo Fisher Scientific

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600

Piper Sandler analyst David Westenberg maintains Thermo Fisher Scientific (NYSE:TMO) with a Neutral and raises the price target from $510 to $600.

Benzinga Newsdesk

Thermo Fisher Scientific Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Thermo Fisher Scientific Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750

PRO
CNBC Halftime Report Final Trades: Nutrien, Horizon Kinetics Inflation Beneficiaries ETF, Wells Fargo, Thermo Fisher Scientific

PRO
UBS Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $730

PRO
CLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748

PRO
CNBC Halftime Report Final Trades: Interactive Brokers Group, Target, Delta Air Lines, Thermo Fisher Scientific

PRO
Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600

People Also Watch

People Also Watch

Thermo Fisher Scientific Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Thermo Fisher Scientific Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBarclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750

PROCNBC Halftime Report Final Trades: Nutrien, Horizon Kinetics Inflation Beneficiaries ETF, Wells Fargo, Thermo Fisher Scientific

PROUBS Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $730

PROCLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748

PROCNBC Halftime Report Final Trades: Interactive Brokers Group, Target, Delta Air Lines, Thermo Fisher Scientific

PROPiper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600

People Also Watch

People Also Watch

PRO
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $750

PRO
CNBC Halftime Report Final Trades: Nutrien, Horizon Kinetics Inflation Beneficiaries ETF, Wells Fargo, Thermo Fisher Scientific

PRO
UBS Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $730

PRO
CLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748

PRO
CNBC Halftime Report Final Trades: Interactive Brokers Group, Target, Delta Air Lines, Thermo Fisher Scientific

PRO
Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600